Alió J L, Mulet M E, Haroun H, Merayo J, Ruiz Moreno J M
Vissum/Instituto Oftalmológico de Alicante, Avda de Denia s/n, Edificio Vissum, 03016 Alicante, Spain.
Br J Ophthalmol. 2004 Dec;88(12):1585-9. doi: 10.1136/bjo.2004.046375.
To study the anatomical and visual performance following implantation of a model of artificial cornea and to evaluate the postoperative long term complications.
11 eyes of 11 patients with bilateral corneal blindness considered as potentially having high risk of failure of penetrating corneal keratoplasty were implanted with biocolonisable Kpro keratoprosthesis (BIOKOP I, FCI, Rantigny, France) in the period between January 1996 and May 1998. Only one eye was implanted in all patients and followed up for a period of 60 months. The visual outcome, anatomical and functional stability, complications, and the general performance of the keratoprosthesis were evaluated.
The keratoprosthesis (BIOKOP I) only 36.3% remained in position to date. In the patients' last visit five eyes (45.4%) were blind and one (9.0%) showed a slight improvement in the best corrected visual acuity (BCVA) in comparison to preoperative tests. Six eyes (54.5%) showed improved BCVA before having postoperative complications. Four eyes underwent replacement of a BIOKOP I Kpro with a BIOKOP II as a result of extrusion. The keratoprostheses remained anatomically in situ for a mean of 25.5 months and their functional performance period was limited to a mean of 22 months.
Corneal keratoprosthesis (BIOKOP I, II) does not provide a stable anatomical relation with the surrounding ocular structures. Its ability to restore vision is limited to a short postoperative period in eyes implanted with severe ocular surface disease.
研究人工角膜模型植入后的解剖结构和视觉性能,并评估术后长期并发症。
1996年1月至1998年5月期间,对11例双侧角膜盲且被认为穿透性角膜移植术失败风险较高的患者的11只眼植入了可生物定植的Kpro角膜假体(BIOKOP I,FCI,法国兰蒂尼)。所有患者仅植入一只眼,并随访60个月。评估视觉结果、解剖和功能稳定性、并发症以及角膜假体的总体性能。
截至目前,角膜假体(BIOKOP I)仅36.3%仍在位。在患者的最后一次随访中,5只眼(45.4%)失明,1只眼(9.0%)与术前检查相比最佳矫正视力(BCVA)有轻微改善。6只眼(54.5%)在出现术后并发症前BCVA有所改善。4只眼因假体挤出而将BIOKOP I Kpro更换为BIOKOP II。角膜假体在解剖学上原位保留的平均时间为25.5个月,其功能发挥期平均限于22个月。
角膜假体(BIOKOP I、II)与周围眼结构未形成稳定的解剖关系。在植入患有严重眼表疾病的眼中,其恢复视力的能力仅限于术后短期内。